Vericel (VCEL) Cash & Current Investments (2010 - 2026)
Vericel's (VCEL) quarterly Cash & Current Investments came in at $145.3 million in Q1 2026, up 82.35% year-on-year from $79.7 million in Q1 2025, and up 5.7% quarter-over-quarter from $137.5 million in Q4 2025.
Vericel (VCEL) Cash & Current Investments (2010 - 2026) Analysis & Trends
Vericel has disclosed Cash & Current Investments across 15 years of filings, most recently posting $145.3 million for Q1 2026.
- Cash & Current Investments for Q1 2026 came in at $145.3 million, up 82.35% year-over-year; the trailing twelve-month figure through Mar 2026 was $145.3 million (up 82.35% YoY), and the FY2025 annual result was $137.5 million, up 18.32% from the prior year.
- Cash & Current Investments came in at $145.3 million for Q1 2026 at Vericel, up from $137.5 million in the prior quarter.
- In the past five years, Cash & Current Investments ranged from a high of $145.3 million in Q1 2026 to a low of $51.1 million in Q4 2022.
- The 5-year median for Cash & Current Investments is $100.7 million (2022), against an average of $101.7 million.
- Across the five-year window, Cash & Current Investments plunged 50.61% in 2022 and surged 92.44% in 2025, its largest moves.
- Vericel's Cash & Current Investments stood at $51.1 million in 2022, then jumped by 70.1% to $86.9 million in 2023, then jumped by 33.78% to $116.2 million in 2024, then gained by 18.32% to $137.5 million in 2025, then rose by 5.7% to $145.3 million in 2026.
- The last three Cash & Current Investments figures came in at $145.3 million (Q1 2026), $137.5 million (Q4 2025), and $135.4 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 32.30 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 2.13 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 286.70 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 18.44 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 2.77 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 7.20 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 7.25 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Vericel | 2.04 Bn | 1.90 Bn | 49.27 Mn | 145.34 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 145.34 Mn |
| Dec 31, 2025 | 137.50 Mn |
| Sep 30, 2025 | 135.38 Mn |
| Jun 30, 2025 | 80.53 Mn |
| Mar 31, 2025 | 79.71 Mn |
| Dec 31, 2024 | 116.21 Mn |
| Sep 30, 2024 | 70.35 Mn |
| Jun 30, 2024 | 102.51 Mn |
| Mar 31, 2024 | 110.65 Mn |
| Dec 31, 2023 | 86.87 Mn |
| Sep 30, 2023 | 83.56 Mn |
| Jun 30, 2023 | 97.83 Mn |
| Mar 31, 2023 | 119.28 Mn |
| Dec 31, 2022 | 51.07 Mn |
| Sep 30, 2022 | 110.94 Mn |
| Jun 30, 2022 | 100.69 Mn |
| Mar 31, 2022 | 100.55 Mn |
| Dec 31, 2021 | 103.40 Mn |
| Sep 30, 2021 | 98.29 Mn |
| Jun 30, 2021 | 90.98 Mn |